ImmunoCellular Therapeutics Ltd (NYSEAMERICAN:IMUC)’s share price shot up 0% on Friday . The company traded as high as $0.36 and last traded at $0.34. 1,725,626 shares changed hands during trading, a decline of 47% from the average session volume of 3,260,000 shares. The stock had previously closed at $0.34.

Separately, Maxim Group reiterated a “hold” rating on shares of ImmunoCellular Therapeutics in a research note on Thursday, August 24th.

ILLEGAL ACTIVITY NOTICE: “ImmunoCellular Therapeutics Ltd (IMUC) Trading 0% Higher” was first posted by Daily Political and is the sole property of of Daily Political. If you are accessing this report on another website, it was stolen and reposted in violation of US & international copyright laws. The legal version of this report can be viewed at https://www.dailypolitical.com/2017/11/12/immunocellular-therapeutics-ltd-imuc-trading-0-higher.html.

About ImmunoCellular Therapeutics

ImmunoCellular Therapeutics, Ltd. is a clinical-stage biotechnology company. The Company is developing immune-based therapies for the treatment of cancers. The Company’s cancer immunotherapies target cancer stem cells (CSCs), which are the drivers of tumor growth and disease recurrence. Its product candidate is ICT-107, which is in phase III testing.

Receive News & Ratings for ImmunoCellular Therapeutics Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoCellular Therapeutics Ltd and related companies with MarketBeat.com's FREE daily email newsletter.